Bioventus BVS reported its Q4 earnings results on Thursday, March 10, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Bioventus beat estimated earnings by 44.44%, reporting an EPS of $0.26 versus an estimate of $0.18.
Revenue was up $31.82 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.11 which was followed by a 0.36% drop in the share price the next day.
Here's a look at Bioventus's past performance:
Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
---|---|---|---|---|
EPS Estimate | 0.14 | 0.15 | 0.09 | 0.23 |
EPS Actual | 0.25 | 0.16 | 0.15 | 2.32 |
Revenue Estimate | 102.23M | 97.64M | 76.54M | 98.12M |
Revenue Actual | 108.89M | 109.82M | 81.78M | 98.59M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.